We are very excited to announce our indoor Biotech Innovation & Vendor Expo at the Cambridge Marriott. Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. This biotech community event will bring together researchers from local biotech/pharma accounts in Cambridge/Boston...
Never has so much been at stake when it comes to investments in health care. All kinds of uncertainty — political, social, and scientific — stand between new preventatives, treatments, and cures and the patients who need them. But never has investment been more important either. Join us for a look at what is at...
Selecting the right CRO is one of the most critical decisions in clinical development, yet rarely a straightforward one. Sponsors often find that comparing CRO proposals isn’t an apples-to-apples exercise — with variations in assumptions, timelines, and resource structures making true comparisons difficult. This session draws on insights from more than $2B in CRO selections...
Greater Philadelphia sits at the forefront of a dynamic life sciences evolution, where strategic decision-making today will shape the trajectory of the region’s biotech and innovation economy for years to come. As funding landscapes shift, groundbreaking research emerges, and tenant demands evolve, stakeholders across commercial real estate, including developers, investors, and brokers, need critical insights...
What You'll Learn: How will lower interest rates influence biotech funding, investment flows, and real estate capital allocation in 2025? With a record volume of new lab and GMP supply delivering this year, how can owners make their assets stand out in a crowded market? Is renewed activity in biotech IPOs and venture funding a...
AAV vectors offer clear benefits for gene therapy, and continued advances in technology have increased target specificity, improved potency, and intensified production efficiency. Even with significant attention early in development, analytical activities for gene therapy often land on the critical path. This webinar provides considerations for phase-appropriate AAV characterization and release activities from pre-clinical to...
Alzheimer’s disease is the most common cause of dementia. It is associated with the build-up of small protein aggregates in the brain, termed β-amyloid plaques, ultimately leading to brain damage and memory loss. Overall, more women are affected by Alzheimer’s disease than men, but the reasons for these differences are not fully understood. Elucidating these...
Spotlight Panels: A New Way to Maximize Visibility for Innovative Biotech Companies In a rapidly changing world, scientific discovery has the power to transform the health and wellbeing of everyday people — yet the pace of innovation often outstrips public understanding, policy adaptation, and ethical reflection. This session of The Briefing Room explores how to...
Join us for an insightful webinar featuring industry-leading experts as they explore the critical factors influencing bioprocessing in cell and gene therapies. Through a dynamic panel discussion, we’ll delve into the most important criteria when selecting processing tools and containers, and discuss the current state of technology that is "good enough" for today’s needs. Participants...
We are very excited to invite you to our BVS Holiday Biotech Community Event - an evening of celebration, networking, and festive cheer! Mark your calendars for a great opportunity to connect with industry leaders, explore innovative products, and mingle with fellow professionals in the biotech community. This special event is designed exclusively for all...
This webinar explores the latest advancements in RNA manufacturing, with a particular emphasis on the scalability of production processes. Special attention is given to capping strategies, highlighting their critical role in ensuring RNA stability and translational efficiency at industrial scales. Attendees will gain insights into current challenges and innovative solutions for optimizing capping processes in...
Cleanrooms hosting pharmaceutical manufacturing operations are inspected at a critical scale to ensure compliance to regulatory standards. With this comes a responsibility to the manufacturing operations, quality, facility maintenance groups and the design professional team to provide a pathway to achieve regulatory approval. We will explore critical lessons from FDA 483 observations and Warning Letters...
